Detalles de la búsqueda
1.
In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo.
Ann Intern Med
; 177(5): JC54, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710085
2.
P2Y12 inhibitor monotherapy 1 to 3 mo after PCI did not differ from standard DAPT for fatal or ischemic events.
Ann Intern Med
; 176(6): JC66, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276597
3.
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation
; 145(3): e4-e17, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34882436
4.
In HFpEF, adding empagliflozin to usual care reduced a composite of CV death or HF hospitalization at a median 26 mo.
Ann Intern Med
; 175(1): JC4, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34978853
5.
Left main coronary disease: evolving management concepts.
Eur Heart J
; 43(44): 4635-4643, 2022 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36173870
6.
In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
Ann Intern Med
; 174(3): JC30, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33646848
7.
Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent angina.
Ann Intern Med
; 173(4): JC15, 2020 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32805176
8.
In stable coronary disease with moderate or severe ischemia, initial invasive therapy plus medical therapy did not improve CV outcomes at 3 years.
Ann Intern Med
; 173(4): JC14, 2020 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32805178
9.
Examination of the Neck Veins.
N Engl J Med
; 384(9): e29, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657307
10.
Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.
Eur Heart J
; 39(2): 102-110, 2018 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29029035
11.
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation
; 145(3): e18-e114, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34882435
12.
Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline program.
Am Heart J
; 197: 9-17, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447789
13.
Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes.
N Engl J Med
; 381(14): 1373-1375, 2019 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31475797
14.
Percutaneous coronary intervention strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
Curr Opin Cardiol
; 32(6): 755-760, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28759470
15.
The effect of high-risk ST elevation myocardial infarction transfer patients on risk-adjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline program.
Am Heart J
; 180: 74-81, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27659885
16.
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
Am Heart J
; 173: 108-17, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26920603
17.
In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes.
Ann Intern Med
; 171(8): JC46, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31610559
18.
In patients with suspected AMI and LBBB, algorithms based on ECG and troponin data were tested to rule MI in or out.
Ann Intern Med
; 171(8): JC47, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31610560
19.
After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placebo.
Ann Intern Med
; 170(12): JC62, 2019 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31207615
20.
Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes.
JAMA
; 324(16): 1613-1615, 2020 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33107925